SignalTech/AI
Anthropic is running its own drug programs after acquiring a one-person biotech
Anthropic acquired a one-person biotech to launch its own drug programs.
Context
What happened: Anthropic released early results from drug development work with six partners, including Bristol Myers Squibb, after acquiring a one-person biotech and running its own drug programs.
Why it matters: The results mark Anthropic's move into drug development alongside established pharmaceutical partners, extending its work beyond its core business.
What changed
Anthropic released early results from drug development work with six partners, including Bristol Myers Squibb, after acquiring a one-person biotech and running its own drug programs.
Why it matters
The results mark Anthropic's move into drug development alongside established pharmaceutical partners, extending its work beyond its core business.